Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2026
Employees
5,730
Stocks News & Analysis
stocks
BlackRock earnings: Market gains and inflows drive AUM and revenue to record highs
stocks
Our view of ANZ’s strategic plan
stocks
Perplexing buyback from overvalued ASX share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,299.00 | 21.90 | 0.24% |
CAC 40 | 8,077.00 | 157.38 | 1.99% |
DAX 40 | 24,181.37 | 55.57 | -0.23% |
Dow JONES (US) | 46,297.32 | 26.86 | 0.06% |
FTSE 100 | 9,424.75 | 28.02 | -0.30% |
HKSE | 25,910.60 | 469.25 | 1.84% |
NASDAQ | 22,638.31 | 116.61 | 0.52% |
Nikkei 225 | 47,672.67 | 825.35 | 1.76% |
NZX 50 Index | 13,307.40 | 30.41 | 0.23% |
S&P 500 | 6,666.18 | 21.87 | 0.33% |
S&P/ASX 200 | 8,990.90 | 22.20 | 0.25% |
SSE Composite Index | 3,912.21 | 46.98 | 1.22% |